Moreover, CNTN1 expression varies with tumor grade and primary tumor site, with higher expression observed in less aggressive grade 1 tumors, as well as tumors originating from the thorax, a clinically favorable primary site, compared to those in the adrenal gland. Here, CNTN1 is linked to neoplasm.